Thomas Foster

Professor Thomas Foster leads the overall Life Sciences strategy practice with a focus on providing financial opinions, strategic and financial consulting and transaction support services.

Prior to joining IIBD, Professor Foster was a Vice President in charge of IMS Management Consulting where he was a leader for the company’s global consulting practice for seven years. In this position, Prof. Foster oversaw significant portions of IMS’s 1000 person $400 million global consulting practice providing services in strategic marketing, new product planning, licensing, lifecycle planning and market research. Over the past 15 years, Prof Foster has supported over 120 brands with strategy support, and as an industry practitioner has guided the commercial input into over 100 clinical programs. Prof. Foster’s primary focus has been in the areas of oncology, cardiovascular & metabolic, women’s health and neuroscience therapeutic areas.

Previous to IMS, Prof. Foster was Senior Vice President for Cambridge Pharmaceutical Consultancy’s Commercial Strategy practice. Prior to Cambridge, Prof. Foster was practice leader for PAREXEL International’s Benchmarking & Performance Management group, and he served as Chief Operating Officer for Helix Research.

He is a frequent author and speaker on various commercial and R&D life science issues, and has contributed to articles appearing in The Economist, The New York Times, Wall Street Journal, Time, and other publications. Prof. Foster is a Scholar at the Massachusetts Institute of Technology (MIT) participating in the institution’s think tank - The Center for Biomedical Innovation.